Patent Cases
Cases 1 - 10 of 313
RSS Feed | View as table | Sort by last update
In Re: Aflibercept Patent Litigation
as 1:2024md03103
Not Yet Classified: AFLIBERCEPT PATENT LITIGATION
Plaintiff: Regeneron Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals, Inc., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1402
Plaintiff: REGENERON PHARMACEUTICALS, INC.
Defendant: MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC. and AMGEN USA, INC.
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1405
Plaintiff: REGENERON PHARMACEUTICALS, INC.
Defendant: MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC. and AMGEN USA, INC.
Novo Nordisk, Inc. et al v. Viatris Inc. et al
as 1:2023cv00013
Plaintiff: Novo Nordisk, Inc. and Novo Nordisk A/S
Defendant: Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AstraZeneca AB v. Mylan Pharmaceuticals Inc.
as 23-1267
Plaintiff / Appellee: ASTRAZENECA AB and ASTRAZENECA PHARMACEUTICALS LP
Defendant / Appellant: MYLAN PHARMACEUTICALS INC. and KINDEVA DRUG DELIVERY L.P.
AstraZeneca AB v. Mylan Pharmaceuticals Inc.
as 23-1164
Plaintiff / Appellant: ASTRAZENECA AB and ASTRAZENECA PHARMACEUTICALS LP
Defendant / Appellee: MYLAN PHARMACEUTICALS INC. and KINDEVA DRUG DELIVERY L.P.
Merck Sharp & Dohme, LLC v. Mylan Pharmaceuticals Inc.
as 23-1013
Plaintiff / Appellee: MERCK SHARP & DOHME, LLC
Defendant / Appellant: MYLAN PHARMACEUTICALS INC.
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. We have downloadable decisions or orders for this case
as 1:2022cv00061
Plaintiff: Regeneron Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals Inc.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
MOMENTA PHARMACEUTICALS, INC. v. MYLAN PHARMACEUTICALS, INC. et al
as 2:2022cv00750
Plaintiff: MOMENTA PHARMACEUTICALS, INC.
Defendant: MYLAN PHARMACEUTICALS, INC., MYLAN, INC., VIATRIS, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al We have downloadable decisions or orders for this case
as 1:2022cv00035
Plaintiff: AstraZeneca AB and Astrazeneca Pharmaceuticals LP
Defendant: Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?